Compare AANJANEYA LIFECARE with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS J.B.CHEMICALS DR. DATSONS LABS/
J.B.CHEMICALS
 
P/E (TTM) x -10.9 16.7 - View Chart
P/BV x 0.2 2.3 7.0% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 DR. DATSONS LABS   J.B.CHEMICALS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
J.B.CHEMICALS
Mar-18
DR. DATSONS LABS/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs126363 34.6%   
Low Rs31255 12.1%   
Sales per share (Unadj.) Rs133.0169.1 78.6%  
Earnings per share (Unadj.) Rs0.216.6 0.9%  
Cash flow per share (Unadj.) Rs6.623.4 28.2%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs128.8172.5 74.7%  
Shares outstanding (eoy) m31.6683.57 37.9%   
Bonus/Rights/Conversions FCCBBB-  
Price / Sales ratio x0.61.8 32.2%   
Avg P/E ratio x516.118.6 2,772.1%  
P/CF ratio (eoy) x11.813.2 89.7%  
Price / Book Value ratio x0.61.8 33.9%  
Dividend payout %012.0 0.0%   
Avg Mkt Cap Rs m2,47725,827 9.6%   
No. of employees `000NA3.8 0.0%   
Total wages/salary Rs m562,511 2.2%   
Avg. sales/employee Rs ThNM3,747.4-  
Avg. wages/employee Rs ThNM665.7-  
Avg. net profit/employee Rs ThNM367.8-  
INCOME DATA
Net Sales Rs m4,21114,135 29.8%  
Other income Rs m79366 21.5%   
Total revenues Rs m4,28914,501 29.6%   
Gross profit Rs m5692,178 26.1%  
Depreciation Rs m204570 35.9%   
Interest Rs m43035 1,232.7%   
Profit before tax Rs m131,940 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6552 1.1%   
Profit after tax Rs m51,387 0.3%  
Gross profit margin %13.515.4 87.6%  
Effective tax rate %48.028.5 168.7%   
Net profit margin %0.19.8 1.2%  
BALANCE SHEET DATA
Current assets Rs m6,85210,470 65.4%   
Current liabilities Rs m6,7112,749 244.1%   
Net working cap to sales %3.354.6 6.1%  
Current ratio x1.03.8 26.8%  
Inventory Days Days16155 291.4%  
Debtors Days Days31878 410.1%  
Net fixed assets Rs m3,6735,811 63.2%   
Share capital Rs m317167 189.5%   
"Free" reserves Rs m3,76114,248 26.4%   
Net worth Rs m4,07814,416 28.3%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63317,649 71.6%  
Interest coverage x1.056.6 1.8%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.8 41.6%   
Return on assets %3.48.1 42.7%  
Return on equity %0.19.6 1.2%  
Return on capital %7.713.7 56.0%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9646,164 15.6%   
Fx outflow Rs m6071,334 45.5%   
Net fx Rs m3574,829 7.4%   
CASH FLOW
From Operations Rs m1,3451,231 109.3%  
From Investments Rs m-2,256-208 1,083.9%  
From Financial Activity Rs m-1,200-595 201.6%  
Net Cashflow Rs m-2,111427 -494.2%  

Share Holding

Indian Promoters % 4.5 55.4 8.2%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 0.0 3.4 -  
FIIs % 1.4 3.9 34.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 37.0 254.3%  
Shareholders   20,807 30,437 68.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   SUN PHARMA  PROCTER & GAMBLE HEALTH  NOVARTIS  FULFORD INDIA  DR. REDDYS LAB  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slips Over 300 Points; Axis Bank & Tech Mahindra Top Losers(12:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red. Barring consumer durables sector, all sectoral indices are trading in red with stocks in the telecom sector.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - DIVIS LABORATORIES COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS